145020 - Hugel, Inc.

145020 Summary
Biopharma
Stock Price & Overview
₩243,000 -1,000 (-0.41%) Close · Sep 7, 2026 KST
KOSDAQ | ₩KRW | Close: ₩243,000  ≈ US$174  ·  Market cap ₩3.0tn (≈ $2.2bn)

Investor Relations Event

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 기업설명회(IR)개최

145020

Price
₩243,000
Change
-0.41%
Market cap
₩3.0tn
Prev. close
₩244,000
145020 SummaryCompare to Peers

145020 data on kstock

Financials
11 fiscal years

Every figure is taken from Hugel, Inc.'s own DART filings and matched on IFRS account codes, so a line holds across years where the Korean wording changed.

More 145020 filings

Large business group status disclosure — quarterly, individual company

08/31/26

Results of an extraordinary general meeting

08/24/26

Insider / Major Shareholder Holdings Report

08/21/26

Appointment, dismissal or early departure of an independent director

08/21/26

Results of an extraordinary general meeting

08/21/26

Half-Year Report

08/14/26
All 145020 filings